Specification: |
The Tosufloxacin , with the CAS register number 108138-46-1, has the systematic name of 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid , and it has other names as Tosufloxacin Tosyiate ; 7-(3-Amino-1-pyrrolidinyl)-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid ; dl-Tosufloxacin ; TOSUFLOXACIN(SUBJECTTOPATENTFREE) ; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid .
The physical properties of this chemcial are as followings: (1)ACD/LogP: 1.22 ; (2)ACD/LogD (pH 5.5): -1.34 ; (3)ACD/LogD (pH 7.4): -1.14 ; (4)ACD/BCF (pH 5.5): 1 ; (5)ACD/BCF (pH 7.4): 1 ; (6)ACD/KOC (pH 5.5): 1 ; (7)ACD/KOC (pH 7.4): 1 ; (8)#H bond acceptors: 7 ; (9)#H bond donors: 3 ; (10)#Freely Rotating Bonds: 4 ; (11)Polar Surface Area: 65.98 ; (12)Index of Refraction: 1.645 ; (13)Molar Refractivity: 94.1 cm3 ; (14)Molar Volume: 259.4 cm3 ; (15)Polarizability: 37.3× 10-24 cm3 ; (16)Surface Tension: 67.8 dyne/cm ; (17)Density: 1.558 g/cm3 ; (18)Flash Point: 325.4 °C ; (19)Enthalpy of Vaporization: 95.85 kJ/mol ; (20)Boiling Point: 614.4 °C at 760 mmHg ; (21)Vapour Pressure: 5.96E-16 mmHg at 25°C.
As for its usage, it is usually used in curing respiractory tract infections, skin soft tissue infection aroused by the sensitive bacteria. Its product categories are various, including Active Pharmaceutical Ingredients, Tosufloxacin while the preparation product is tosufloxacin tosilate.
Additionally, you could convert the following data information into the molecular structure:
SMILES:Fc4ccc(N/2c1nc(c(F)cc1C(=O)C(\C(=O)O)=C\2)N3CCC(N)C3)c(F)c4
InChI:InChI=1/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29)
InChIKey:WUWFMDMBOJLQIV-UHFFFAOYAR
As for its market information, you could find many suppliers in China, such as Beijing Tongqing Putian Science & Technology Development Co., Ltd , Xingcheng Chempharm Co., Ltd , and LGM Pharmaceuticals .
|